AKT1 and non-small cell lung carcinoma: The preventive mechanism in smoking-associated NSCLC was evident by a study showing EGCG’s action in downregulating pro-inflammatory cyclooxygenase 2 (COX2), AKT, ERK, and HIF1A in nicotine-treated cells [124].